Sort
48,018 grants matching “immunotherapy”
Structure-based engineering of immune cytokine signaling
$517,818Kenan Christopher Garcia · Stanford University · R01 · FY2023 · AI
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
$517,798Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA
Molecular and Cellular Immunology
$517,734Jason G. Cyster · University Of California, San Francisco · T32 · FY2021 · AI
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$517,622Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Role of LAM-specific TREM1 in leukemogenesis
$517,618Wei Du · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Role of LAM-specific TREM1 in leukemogenesis
$517,618Wei Du · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES
$517,563Warren S Pear · University Of Pennsylvania · T32 · FY2018 · CA
UCLA Tumor Immunology Institutional Traning Grant
$517,558Michael A Teitell · University Of California Los Angeles · T32 · FY2020 · CA
An integrated polymeric carrier for subunit cancer vaccines
$517,545Suzie H Pun · University Of Washington · R01 · FY2025 · CA
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
$517,519Victor H. Engelhard · University Of Virginia · R01 · FY2019 · CA
Vaccine and radiation for the therapy of human cancers
$517,502James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$517,502James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
$517,432Richard J Price · University Of Virginia · R01 · FY2018 · CA
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$517,415Justin M Balko · Vanderbilt University Medical Center · R01 · FY2021 · CA
Immunologic Monitoring and Cellular Products Laboratory
$517,408Yen-Michael S. Hsu · University Of Pittsburgh At Pittsburgh · P30 · FY2024 · CA
Immunologic Monitoring and Cellular Products Laboratory
$517,408Yen-Michael S. Hsu · University Of Pittsburgh At Pittsburgh · P30 · FY2022 · CA
Immunologic Monitoring and Cellular Products Laboratory
$517,408Yen-Michael S. Hsu · University Of Pittsburgh At Pittsburgh · P30 · FY2023 · CA
Cooperation of Co-Amplified Genes in Hepatocellular Carcinoma
$517,389Devanand Sarkar · Virginia Commonwealth University · P01 · FY2025 · CA
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
$517,362Melissa B Davis · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Nanotechnology Enabled Selection of MHC-Peptide Ligands to Personalize Cancer Therapy
$517,321Georgios Alexandrakis · University Of Texas Arlington · R21 · FY2020 · CA
Role of Neutralizing Antibodies in Transmission of SHIV
$517,305Nancy Logan Haigwood · Seattle Biomedical Research Institute · R01 · FY2007 · HD
Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck Cancers
$517,263Wenbin Lin · University Of Chicago · R01 · FY2020 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$517,238Aleksander S. Popel · Johns Hopkins University · R01 · FY2022 · CA
Project 1
$517,215Ann G Schwartz · Wayne State University · P20 · FY2022 · CA
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer
$517,072David A Mankoff · University Of Pennsylvania · R01 · FY2023 · CA